Michelle Mack Email & Phone Number
Vice President, Business Development @ Orakl Oncology
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Michelle Mack Location
- New York, NY, US
Michelle Mack Work
- Vice President, Business Development @ (April 2026 - Present)
- Senior Director of Business Development, Biological Modeling @ Tempus AI (October 2023 - March 2026)
- Vice President of Business Development, Americas @ (March 2023 - July 2023)
- Vice President of Business Development, North America @ Imagen Therapeutics (April 2022 - December 2022)
- Vice President and General Manager, Data Commercialization @ (May 2021 - February 2022)
- Head of Business Development, US-East @ (May 2019 - April 2021)
- Senior Director, Business Development @ (April 2018 - April 2019)
- Senior Director of Business Development, Mid-Atlantic and Central US @ Crown Bioscience, Inc. (December 2017 - March 2018)
- Director of Business Development @ Crown Bioscience, Inc. (April 2016 - December 2017)
- Senior Scientist, Antibody Drug Conjugate Biology @ (September 2013 - April 2016)
- Research Scientist, Antibody Drug Conjugate Biology @ (September 2009 - September 2013)
- Research Scientist, Antibody Technologies @ (June 2006 - September 2009)
- Scientist, Immunology @ (November 2004 - June 2006)
- Associate Scientist, Hybridoma @ (June 2001 - November 2004)
Michelle Mack Education
- Seton Hall University
Doctor of Philosophy (Ph.D.) (Molecular Bioscience)
2011-2017 - Rochester Institute of Technology
Bachelor of Science (BS) (Biotechnology)
2002 - Seton Hall University
Master of Science (M.S.) (Microbiology)
2011
Michelle Mack Skills
- ADCC/CDCC assays
- Animal Modeling
- Animal Tissue Fusions
- Antibodies
- Apoptosis
- Assay Development
- Bacterial Culture
- Binding Assays
- Cell Culture
- Cell Cycle Analysis
- Cell banking
- Drug Resistance
- ELISA
- ELISPOT
- Flow Cytometry
- IF and confocal microscopy
- Internalization Assays
- Intracellular localization techniques
- Luminex
- Mechanism Of Action Studies
- Microbiology
- Monoclonal Antibody Development
- OPA Assays
- PCR
- Proliferation
- SBA Assays
- Software Analysis
- Translational Research
- Vaccines
- Western Blotting
- combination studies
- saporin-mediated cytotoxicity
Michelle Mack Summary
- Michelle Mack, based in New York, NY, US, is currently a Vice President, Business Development at Orakl Oncology. Michelle Mack brings experience from previous roles at Tempus AI, Reaction Biology, Imagen Therapeutics and Champions Oncology, Inc.. Michelle Mack holds a 2011 - 2017 Doctor of Philosophy (Ph.D.) in Molecular Bioscience @ Seton Hall University. With a robust skill set that includes ADCC/CDCC assays, Animal Modeling, Animal Tissue Fusions, Antibodies, Apoptosis and more. Michelle Mack has 1 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michelle Mack?
Find contact details for 700 million professionals.
Others Named Michelle Mack
Michelle Mack
Manufacturing Manager
Chesterfield, GB
Michelle Mack
Shopper Insights - Drug Channel
Chicago, IL, US
Michelle Mack
Owner
Sydney, NSW, AU
Michelle Mack
Chief Executive Officer
Fayetteville, NC, US
Michelle Mack
Vice President, Business Development
New York, NY, US
Michelle Mack
Senior Director, State Affairs
Saint Paul, MN, US
Michelle Mack
General Manager
Miami, FL, US
Top Orakl Oncology Employees
Chelsea Boren
Head of People
Paris, FR
Jérôme Caron
Director of laboratory
Romainville, FR
Mia Cabantous
Associate Scientist
Paris, FR
Thibaud Caspari
Chief of Staff
Paris, FR
Gizem Altay
Principal Scientist
Paris, FR
Michelle Mack
Vice President, Business Development
New York, NY, US
Bérénice van Moere
Chief of Staff
Paris, FR
Benoît Fazi
Senior Software Engineer
Paris, FR
Fanny Jaulin
CEO and Cofounder
Paris, FR
Gustave Ronteix
Co-Founder and CTO
Paris, FR
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co